Earnings Ahead

PRTA - Prothena Corporation plc

68.57 0.95 1.41

Prothena Corporation plc

Prothena Corporation plc

About

Profile


Headquarters

Republic of Ireland


Intraday

High
-
Low
-

52-week

High
-
Low
-

PRTA



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Lilly sends Alzheimer’s drug developers higher after trial data
  • Walgreens, Prothena in pact for early-stage Alzheimer’s trial
  • Prothena GAAP EPS of $0.12 beats by $0.61, revenue of $49.9M beats by $20.76M
  • Prothena says Alzheimer’s candidate was safe in early-stage trial
  • Prothena initiated at overweight at Piper Sandler on antibody platform, pipeline
  • Lilly, Anavex, other Alzheimer's drug developers rise modestly on Biogen lecanemab approval
  • Prothena prices 3.25M shares public offering
  • Prothena falls over 6% after hours on proposed stock offering
  • Biogen rallies Alzheimer’s drug developers after full data for lecanemab
  • Prothena drops 9% as RBC Capital Markets downgrades citing valuation
  • Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data
  • Prothena climbs 80% as Bofa upgrades after rivals’ Alzheimer’s data
  • Biogen, Eisai drive rally in Alzheimer’s stocks as lecanemab succeeds in late-stage trial
  • Prothena GAAP EPS of -$0.88 misses by $0.31
  • Prothena Q2 2022 Earnings Preview
  • Electric vehicle stocks race higher ahead of Tesla earnings
  • Alzheimer’s drug developers are on decline after Roche setback
  • Prothena Q1 2022 Earnings Preview
  • Electric vehicle stocks are sliding with Shanghai COVID outbreak threatening the supply chain
  • Prothena's PRX012 for Alzheimer’s gets FDA nod to enter clinical trial
PEERS
/XLV

XLV

Date Price Open High Low Vol Change ER
Mar 4 30.60 31.97
32.95
30.37
414.19K -5.5%
Mar 3 32.38 33.69
33.93
31.86
623.67K -3.17%
Mar 2 33.44 33.76
34.19
32.58
305.35K 0.09%
Mar 1 33.41 34.17
35.21
32.49
652.07K -3.44%
Feb 28 34.60 34.93
36.25
34.01
399.75K -2.04%
 
Feb 25 35.32 34.65
35.62
33.70
399.25K 2.14%
Feb 24 34.58 30.50
34.99
30.04
603.90K 6.56%
Feb 23 32.45 34.40
34.92
32.34
478.14K -4.98%
Feb 22 34.15 33.44
36.12
33.10
478.54K 1.43%
Feb 18 33.67 33.56
35.34
33.14
747.55K -3.96%
Feb 17 35.06 36.91
37.28
34.37
595.11K -5.9%
Feb 16 37.26 36.72
37.63
36.01
266.33K -0.56%
Feb 15 37.47 35.27
37.74
35.27
305.68K 5.70%
Feb 14 35.45 35.80
36.32
35.13
315.06K -0.17%
Feb 11 35.51 35.89
36.90
34.80
356.15K -1.31%
Feb 10 35.98 35.45
37.94
35.09
519.36K -1.83%
Feb 9 36.65 35.00
37.03
35.00
397.88K 5.35%
Feb 8 34.79 34.38
35.13
33.54
307.18K 0.23%
Feb 7 34.71 33.72
35.64
33.48
348.02K 2.94%